- Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
-
Kim HY, Kim CW
- KMID: 2070072
- Gut Liver.
- 2014 Nov;8(6):580-581.
- doi: 10.5009/gnl14377
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
-
Lee B, Ha SY, Song DH, Lee HW, Cho SY, Park CK
- KMID: 2070085
- Gut Liver.
- 2014 Nov;8(6):662-668.
- doi: 10.5009/gnl13392
BACKGROUND/AIMS: Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression,... -
- CITED
-
- Close
- SHARE
-
- Close
